| Device Classification Name |
Immunoelectrophoretic, Immunoglobulins, (G, A, M)
|
| 510(k) Number |
K190851 |
| Device Name |
HYDRASHIFT 2/4 daratumumab |
| Applicant |
| Sebia |
| 1705 Corporate Dr., Suite 400 |
|
Norcross,
GA
30093
|
|
| Applicant Contact |
Karen Anderson |
| Correspondent |
| Sebia |
| 1705 Corporate Dr., Suite 400 |
|
Norcross,
GA
30093
|
|
| Correspondent Contact |
Karen Anderson |
| Regulation Number | 866.5510 |
| Classification Product Code |
|
| Date Received | 04/02/2019 |
| Decision Date | 05/02/2019 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Immunology
|
| 510k Review Panel |
Immunology
|
| Summary |
Summary
|
| FDA Review |
Decision Summary
|
| Type |
Special
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
|
|